| A review of blinatumomab, a novel immunotherapy MJ Newman, DJ Benani Journal of Oncology Pharmacy Practice 22 (4), 639-645, 2016 | 88 | 2016 |
| Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center R Roberts, R Ruthazer, A Chi, A Grover, M Newman, S Bhat, S Benotti, ... Critical care medicine 40 (2), 406-411, 2012 | 31 | 2012 |
| Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations CF Nobre, MJ Newman, A DeLisa, P Newman Cancer Chemotherapy and Pharmacology 84, 255-263, 2019 | 29 | 2019 |
| Rosiglitazone, but not metformin or glibenclamide, improves glycaemic control and increases islet insulin content CA Lister, GBT Moore, V Piercy, M Newman, H Chapman, SA Smith Diabetologia 42 (suppl 1), A150, 1999 | 24 | 1999 |
| Evaluation of the head and neck cancer patient population and the incidence of hospitalization at an academic medical center LA Hazelden, MJ Newman, S Shuey, JM Waldfogel, VT Brown Journal of Oncology Pharmacy Practice 25 (2), 333-338, 2019 | 16 | 2019 |
| Azacitidine‐induced pericarditis: A case series M Newman, M Malla, I Gojo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (4 …, 2016 | 16 | 2016 |
| Nonadministration of thromboprophylaxis in hospitalized patients with HIV: a missed opportunity for prevention? MJ Newman, PS Kraus, KM Shermock, BD Lau, ER Haut, DB Hobson, ... Journal of hospital medicine 9 (4), 215-220, 2014 | 15 | 2014 |
| Rosiglitazone improves insulin sensitivity and reduces hyperexpression of insulin and amylin mRNA's in pancreatic islets S Smith, D Boam, MA Cawthorne, J Sidaway, M Newman, M Wilkinson, ... Diabetes 47, A94-A94, 1998 | 14 | 1998 |
| Cost-effectiveness of fulvestrant 250 mg versus 500 mg in postmenopausal women with estrogen receptor-positive metastatic breast cancer and disease progression after … MJ Newman, LT Jones, JM Kraft, AR Lee, GM Lech, NM Farrell, ... Journal of Oncology Pharmacy Practice 18 (4), 394-401, 2012 | 12 | 2012 |
| Effects of the leucovorin shortage: Pilot study investigating cost, efficacy, and toxicity comparison of low fixed-dose versus body surface area-adjusted leucovorin dosing in … BR Shank, AH Seung, K Kinsman, MJ Newman, RC Donehower, B Burton Journal of Oncology Pharmacy Practice 23 (3), 163-172, 2017 | 9 | 2017 |
| Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia K Zacholski, B Hambley, E Hickey, S Kashanian, A Li, MR Baer, ... Journal of Oncology Pharmacy Practice 28 (6), 1340-1349, 2022 | 6 | 2022 |
| Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists V Relias, A McBride, MJ Newman, S Paul, S Saneeymehri, G Stanislaus, ... Journal of Oncology Pharmacy Practice 27 (3), 658-672, 2021 | 6 | 2021 |
| Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease K Sanber, K Ye, HL Tsai, M Newman, JA Webster, I Gojo, G Ghiaur, ... Leukemia & Lymphoma 64 (4), 846-855, 2023 | 4 | 2023 |
| Systemic effects of low-dose dopamine during administration of cytarabine J Connelly, DJ Benani, M Newman, B Burton, J Crow, M Levis Journal of Oncology Pharmacy Practice 23 (6), 436-442, 2017 | 3 | 2017 |
| Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis J Tinajero, K El-Shami, X Wu, BD Smith, MJ Newman Leukemia Research Reports 17, 100304, 2022 | 2 | 2022 |
| Establishing the content validity of a student pharmacist patient counseling competency assessment in oncology M Newman, E Pherson, B Burton, E Nemec American Journal of Pharmaceutical Education 86 (6), 8708, 2022 | 1 | 2022 |
| P572: venetoclax and hypomethylating agent combinations for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease K Sanber, K Ye, HL Tsai, M Newman, A Ambinder, A DeZern, T Jain HemaSphere 6, 471-472, 2022 | 1 | 2022 |
| Rosiglitazone reduces overexpression of insulin and amylin mRNA in hypertrophied pancreatic islets SA Smith, D Boam, MA Cawthorne, J Sidaway, M Newman, M Wilkinson, ... DIABETOLOGIA 41, A169-A169, 1998 | 1 | 1998 |
| 1225: HEALTH SYSTEM POLICY IMPLEMENTATION FOR PREVENTION AND MANAGEMENT OF INFILTRATION AND EXTRAVASATION J Crow, C Proctor, M Olsen, L Fuson, S Morgenstern, K Burger, L Roberts, ... Critical Care Medicine 52 (1), S584, 2024 | | 2024 |
| Gemtuzumab Ozogamicin for Cytoreduction in Hyperleukocytosis M Scarlotta, J Webster, M Newman, C Schulz, K Stokvis, AJ Ambinder, ... Blood 140 (Supplement 1), 11747-11748, 2022 | | 2022 |
